View More Recent Stories

Nov 22, 2024 07:32AM Plus Therapeutics (PSTV) to Present Positive FORESEE Clinical Trial Summary
Nov 18, 2024 07:22AM Plus Therapeutics Inc. (PSTV) PT Lowered to $10 at Jones Trading
Nov 15, 2024 07:27AM H.C. Wainwright Reiterates Buy Rating on Plus Therapeutics Inc. (PSTV)
Nov 14, 2024 09:54PM Plus Therapeutics (PSTV) Misses Q3 EPS by 37c
Nov 6, 2024 07:30AM Plus Therapeutics (PSTV) and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Oct 4, 2024 04:16PM Plus Therapeutics (PSTV) Files $100M Mixed Shelf
Oct 1, 2024 07:30AM Plus Therapeutics (PSTV) Reports ReSPECT-GBM Clinical Trial Update
Sep 18, 2024 07:30AM Plus Therapeutics (PSTV) Showcases New Interim ReSPECT-GBM Phase 2 Trial Data
Sep 3, 2024 06:49AM Plus Therapeutics Inc. (PSTV) PT Lowered to $20 at Ascendiant Capital
Aug 14, 2024 05:17PM Plus Therapeutics (PSTV) Misses Q2 EPS by 71c
Aug 13, 2024 07:30AM Plus Therapeutics (PSTV) Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference
Aug 12, 2024 07:30AM Plus Therapeutics (PSTV) Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
Jun 24, 2024 04:10PM Plus Therapeutics (PSTV) Files for 10.77M Share Offering by Selling Stockholders
View More Recent Stories